Effective Dec. 1, 2004, the United States Equestrian Federation (USEF) Equine Drugs and Medications Rule permits the therapeutic use of Surpass, a nonsteroidal anti-inflammatory product (NSAID) recently approved by the FDA for use in horses. This is a topical preparation of 1% diclofenac cream, from IDEXX Pharmaceuticals. (For more information on the FDA approval of Surpass, click
It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.To continue reading this article, become a member of TheHorse.com.
USEF Rule Permits Use of Surpass
- Nov 17, 2004
- Topics:
Related Content
-
Video
Medications in Horse Racing
-
Download
Joint Injections (AAEP Convention 2012)
-
Article
Electrolyte Use in Performance Horses
-
Article
Regulatory Veterinarian Checks in Horse Racing
-
Article
Effects of Behavior-Modifying Drug Investigated (AAEP 2011)
-
Article
Equine NSAID Use: Indications and Complications
-
Article
Bute and Banamine: Avoid Using Together (AAEP 2011)
-
Article
Intravenous PBZ Dosing in Horses (AAEP 2011)
-
Article
Effects of Tramadol Use in Horses (AAEP 2011)
-
Article
Regional Limb Perfusion for Distal Limb Injuries (AAEP 2011)
POLL: Harsh and Soft Training Tones














